Commentary on the challenges of establishing gene medicines as a new class of therapeutics.
McGraw
B F
BF
Valentis, Inc., Burlingame, CA 94010, USA. Ben@valentis.com
D003142:Communication; D015316:Genetic Therapy / Q000639:trends*; D006801:Humans